Áú8Ψһ¹ÙÍø

2023-11-02

×îÐÂÍ»ÆÆ£¡Ë®Äý½º¼¼ÊõÔÙµÇNature £¬¸ßÇ¿ÈÍË®Äý½ºÖÊÁÏÍÙÊֿɵã¡

×îÐÂÍ»ÆÆ£¡Ë®Äý½º¼¼ÊõÔÙµÇNature £¬¸ßÇ¿ÈÍË®Äý½ºÖÊÁÏÍÙÊֿɵã¡
Ë®Äý½ºÖÊÁÏÔÚÖÊÁÏ»¯Ñ§ÁìÓòÕ¹ÏÖÁËÁÉÀ«µÄÓ¦ÓÃÇ°¾° £¬³ÉΪĿ½ñ×îÊܹØ×¢µÄÉúÎïÖÊÁÏ¡£Á¦Ñ§ÐÔÄÜÊÇÖÊÁϵÄÓ¦ÓÃÇ°Ìá £¬È»¶øË®Äý½ºÖÊÁÏÌìÉúÖÊÈõ £¬Ç¿¶ÈµÍ¡¢ÈÍÐÔ²î £¬³ÉΪÏÞÖÆÆäÓ¦ÓõÄÆ¿¾±ÄÑÌâ¡£¶àÄêÀ´ £¬º£ÄÚÍâÑо¿ÈËÔ±Çã×¢´ó×ÚµÄʱ¼äÓ뾫Á¦ £¬ÖÂÁ¦ÓÚ¹¥¿ËÕâÒ»ÄÑÌâ¡ £¿ÉÒÔ˵ £¬ÔÚË®Äý½ºÁìÓò £¬ÕÆÎÕÁ˽â¾öÁ¦Ñ§ÄÑÌâµÄ½¹µã¼¼Êõ £¬¾ÍÓµÓÐÁË¿ªÆôÓ¦ÓÃÖ®ÃŵÄÔ¿³×¡£ÌرðÊǽü¼¸Äê £¬Åãͬ׏¤Òµ½ç¶ÔË®Äý½ºÖÊÁϵÄÇàíù £¬Ïà¹Ø¼¼ÊõµÄÁÙ´²×ª»¯Ù²È»ÒѽøÈë°×ÈÈ»¯¾ºÕù½×¶Î¡£È»¶øʱÖÁ½ñÈÕ £¬ÕâÒ»ÎÊÌâʼÖÕûÓлñµÃÓÐЧ½â¾ö¡£¾¡¹ÜÄ¿½ñÒÑÓжàÖÖÌáÉýË®Äý½ºÁ¦Ñ§ÐÔÄܵÄÒªÁì £¬ÀýÈçË«ÍøÂçÕ½ÂÔÒÔ¼°»ùÓÚ¾ÛÒÒÏ©´¼µÄ½á¹¹ÓÅ»¯Õ½ÂÔ £¬µ«ÕâЩҪÁìÎÞÒ»ÀýÍâÉæ¼°Èß³¤ÖƱ¸Á÷³Ì»ò¿Á¿ÌÖƱ¸Ìõ¼þ £¬ÏÞÖÆÁËÆäÁÙ´²×ª»¯Ó¦Óá£

Á˽â¸ü¶à

2023-08-29

¡¾APSBÍƼö¡¿²¦ÔƼûÈÕ£ºÈ«¾°Õ¹Ê¾µ¥±ÛÈýצÐÍPEG»¯ÒÁÁ¢Ì濵µÄÊÍÒ©»úÖÆÓëÌåÄÚÃüÔË

¡¾APSBÍƼö¡¿²¦ÔƼûÈÕ£ºÈ«¾°Õ¹Ê¾µ¥±ÛÈýצÐÍPEG»¯ÒÁÁ¢Ì濵µÄÊÍÒ©»úÖÆÓëÌåÄÚÃüÔË
»ùÓÚHPLC-Q-Q-TOF MS¼¼ÊõµÄÌåÄÚÒ©´ú¶¯Á¦Ñ§Ñо¿±êÃ÷ £¬Áú8Ψһ¹ÙÍø¿Æ¼¼Ñз¢µÄPEG»¯ÒÁÁ¢Ì濵¼«´óµØ¸ÄÉÆÁËÒÁÁ¢Ì濵µÄÒ©´ú¶¯Á¦Ñ§ÐÐΪ¡¢Äþ¾²ÐÔºÍÓÐЧÐÔ¡£¸ÃÏîÄ¿ÈýÆÚÁÙ´²¼Æ»®ÒÑ»ñµÃCDEͬÒâ¡£

Á˽â¸ü¶à

2022-10-11

Ò½ÁÆÆ÷еÁìÓòºÃ°ïÊÖ£º¾ÛÒÒ¶þ´¼µÄÓ¦ÓÃʵÀý

Ò½ÁÆÆ÷еÁìÓòºÃ°ïÊÖ£º¾ÛÒÒ¶þ´¼µÄÓ¦ÓÃʵÀý
Áú8Ψһ¹ÙÍø¿Æ¼¼ÌṩǧÓàÖÖ¸ßÆ·ÖʾÛÒÒ¶þ´¼ÑÜÉúÎï²úÆ·Ó붨ÖÆЧÀÍ £¬È«·½Î»ÖúÁ¦ÄúµÄÒ½ÁÆÆ÷еÑз¢ÓëÉú²ú£¡

Á˽â¸ü¶à

mRNA LNPsƽ̨ÐÂÆ«Ïò£ºÌåÄÚCAR-T(M)ÁÆ·¨

2022Äê1ÔÂ6ÈÕ £¬ÃÀ¹ú±öϦ·¨ÄáÑÇ´óѧÅåÀ׶ûÂüҽѧԺµÄÑо¿ÈËÔ±ÔÚ¹ú¼ÊÆÚ¿¯¡¶¿Æѧ¡·ÉÏÐû²¼ÁËһƪÌâΪCAR T cells produced in vivo to treat cardiac injuryµÄÑо¿ÂÛÎÄ¡£¸ÃÑо¿±êÃ÷ £¬mRNA LNP×¢Éä¿ÉÔÚÌåÄÚÖ±½ÓÖÆÔìCAR-Tϸ°û £¬Í¨¹ýµ¥´Î×¢ÉämRNA¾Í¿É¹¥»÷Ìض¨Ä¿±ê £¬Àֳɹ¥»÷ÁËСÊóµÄÐÄÔà³ÉÏËάϸ°û £¬»Ö¸´ÐÄÁ¦Ë¥½ßСÊóµÄÐÄÔ๦Ч¡£

17

2022/01

5?15 È«¹úͶ×ÊÕß±£»¤Ðû´«ÈÕ | ÐÄϵͶ×ÊÕß Ð¯ÊÖ¹²Ðж¯

È«¹úͶ×ÊÕß±£»¤Ðû´«ÈÕ Ö¤¼à»á½«5ÔÂ15ÈÕÉèÁ¢Îª¡°È«¹úͶ×ÊÕß±£»¤Ðû´«ÈÕ¡± £¬Ï£Íûͨ¹ýÿÄêÔÚÀιÌÈÕÆÚÔÚÈ«¹ú¹æÄ£ÄÚ¼¯ÖпªÕ¹Ô˶¯ £¬½øÒ»²½ÌᳫÁ¼ÐÔͶ×ÊÎÄ»¯ £¬Ç¿»¯Í¶×ÊÕß±£»¤Òâʶ £¬È«Ãæ¹¹½¨×ʱ¾Êг¡Í¶×ÊÕß±£»¤Ð»¨Ñù £¬Äý¾ÛÊг¡¸÷·½¹²Ê¶ £¬ÐγÉÈËÈËÌåÌù¡¢¹Ø°®¡¢¹Ø×¢ÖÐСͶ×ÊÕßÕýµ±È¨ÒæµÄÁ¼ºÃÆø·Õ¡£

13

2021/05

¾ÛÒÒ¶þ´¼±ê׼Ʒ

Äý½ºÉø͸ɫÆ×(GPC)·¨²â¶¨´ó·Ö×Ó¾ÛºÏÎïµÄ·Ö×ÓÁ¿ºÍ¶àÊèÉ¢¶È £¬¾ßÓвÙ×÷¼òµ¥ £¬¾­¼Ã¿ìËÙµÈÓŵã £¬Òò´ËÔÚ¸÷ÐÐÒµ»ñµÃ¹ã·ºµÄʹÓ᣹ØÓÚÕâÖÖÒªÁìÀ´Ëµ £¬Ôڲⶨ´ý²âÑùƷʱ £¬ÐèҪѡÔñ±ê׼ƷÀ´×ö±ê×¼ÇúÏß £¬Òò´Ë¹ØÓÚ׼ȷ²â¶¨¸ß·Ö×Ó¾ÛºÏÎïµÄ·Ö×ÓÁ¿À´Ëµ £¬±ê׼ƷµÄÕýÈ·Ñ¡Ôñ¾ÍÏÔµÃÓÈΪÖØÒª¡£¡¡¡¡Êг¡ÉÏÓжàÖָ߷Ö×Ó¾ÛºÏÎï¿ÉÒÔÓÃÓÚÆÊÎö¾ÛÒÒ¶þ´¼µÄ·Ö×ÓÁ¿ºÍ¶àÊèÉ¢¶È,ºÃ±È¾Û±½ÒÒÏ©,¾Û¼×»ù±ûÏ©Ëá¼×õ¥µÈ¡£ÓÃÓÚ¾ÛÒÒ¶þ´¼ÆÊÎö×î׼ȷµÄ±ê׼ƷӦ¸ÃÊǾÛÒÒ¶þ´¼±ê׼Ʒ¡£¡¡¡¡Áú8Ψһ¹ÙÍø¿Æ¼¼Éú²úµÄ¾ÛÒÒ¶þ´¼±ê׼Ʒ¾ßÓзÖ×ÓÁ¿×¼È· £¬¶àÊèÉ¢¶ÈС £¬¹æÄ£¿íµÈÌصã¡£Áú8Ψһ¹ÙÍø¿Æ¼¼¾ÛÒÒ¶þ´¼±ê׼ƷÓÃMALDI-TOFµÄÒªÁ쾫Ãܲⶨ¾ÛÒÒ¶þ´¼±ê׼ƷµÄ·Ö×ÓÁ¿ £¬½ÓÄÉGPCµÄÒªÁì½øÐжàÊèÉ¢¶ÈÆÊÎö £¬·Ö×ÓÁ¿¹æģΪ2000-40000¡£¡¡¡¡¼×Ñõ»ù¾ÛÒÒ¶þ´¼ÏµÁоÛÒÒ¶þ´¼±ê׼Ʒ°üÀ¨ÒÔÏ·Ö×ÓÁ¿µÄ±ê׼Ʒ£ºM-PEG-2000;M-PEG-5000;M-PEG-10K;M-PEG-20K;M-PEG-40K¡£¡¡¡¡¶à±Û¾ÛÒÒ¶þ´¼ÏµÁоÛÒÒ¶þ´¼±ê׼Ʒ°üÀ¨ÒÔÏ·Ö×ÓÁ¿µÄ±ê׼Ʒ£º4ARM-PEG-2000;4ARM-PEG-5000;4ARM-PEG-10K;4ARM-PEG-20K;4ARM-PEG-40K¡£

20

2019/03

ÍøÕ¾µØͼ